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Edited by Robert BaroukiAbstract Extracellular stress proteins including heat shock
proteins (Hsp) and glucose regulated proteins (Grp) are emerg-
ing as important mediators of intercellular signaling and trans-
port. Release of such proteins from cells is triggered by
physical trauma and behavioral stress as well as exposure to
immunological ‘‘danger signals’’. Stress protein release occurs
both through physiological secretion mechanisms and during cell
death by necrosis. After release into the extracellular ﬂuid, Hsp
or Grp may then bind to the surfaces of adjacent cells and initiate
signal transduction cascades as well as the transport of cargo
molecules such as antigenic peptides. In addition Hsp60 and
hsp70 are able to enter the bloodstream and may possess the abil-
ity to act at distant sites in the body. Many of the eﬀects of
extracellular stress proteins are mediated through cell surface
receptors. Such receptors include Toll Like Receptors 2 and 4,
CD40, CD91, CCR5 and members of the scavenger receptor
family such as LOX-1 and SREC-1. The possession of a wide
range of receptors for the Hsp and Grp family permits binding
to a diverse range of cells and the performance of complex mul-
ticellular functions particularly in immune cells and neurones.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Extracellular; Heat; Shock; Protein; Secretion;
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Mammalian stress proteins appear to have been derived
from prokaryotic ancestors that evolved to solve problems in
protein folding [1]. Eukaryotic descendents of these proteins
retain these properties and tend the tertiary and quaternary
structures of a large group of intracellular proteins [2]. The
properties of these proteins in stress involve the direct mainte-
nance of protein structure (chaperoning) as well as the regula-
tion of death pathways. In the heat shock response for
instance, elevated temperatures trigger massive synthesis of
heat shock proteins that fold heat-denatured proteins and
block caspase dependent apoptosis, permitting repair and
thwarting death [3]. Extreme exposure to heat overwhelms
the capacity of intracellular stress proteins and triggers death
[3]. In addition to the intracellular response, stress also triggers*Corresponding author. Fax: +1 617 632 0635.
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doi:10.1016/j.febslet.2007.04.044the release of proteins into the extracellular spaces [4–6]. In-
deed stress proteins such as heat shock proteins (Hsp) 27, 60,
70, 90 and 110 and glucose regulated proteins (Grp) 78, 94,
170 and calreticulin are released from cells in a variety of cir-
cumstances and interact with adjacent cells or in some cases
enter the bloodstream (Table 1). We will discuss here mecha-
nisms by which such proteins are released from cells and the
cell surface structures involved in recognizing them through
autocrine loops, by adjacent cells or at distant sites.
A variety of cell types secrete stress proteins, including neu-
ronal cells, monocytes, macrophages, B cells and tumor cells of
epithelial origin [7–9]. This suggests that stress protein release
is a fairly widespread phenomenon and may be implicated in a
number of physiological or pathological events. Furthermore,
it appears that some cell types may be adapted for specialized
secretion of stress proteins into the blood stream and Hsp70 is
released from brown fat tissue into the circulation in response
to behavioral stress [10]. In addition, Hsps are released from
cells undergoing necrosis after extremes of heat stress or other
toxic treatments [11,12]. Extracellular Hsp60 and hsp70 may
indeed be physiological alarm signals for cell trauma. Just as
Hsp70 release is common to multiple cell types, the ability to
bind stress proteins is also shared by many cell types including
many cells of the haemopoietic lineage, neuronal cells, vascular
and other epithelial cells [13–15].2. Extracellular stress proteins and neuronal cells
The ﬁrst reports of stress protein release involved hsp70
secretion released from neuronal cells along with hsp110 and
actin [16]. Indeed further studies indicate that Hsp70 can be re-
leased from glial cells and then taken up by adjacent neurons
[4,17]. The rationale for this altruistic behavior between diﬀer-
ent neuronal cells appears to be that many neurons have a def-
icit in terms of hsp expression due to inadequate hsp gene
transcription [18] (Fig. 1). The neuronal cytoplasm in the re-
gion of the synapse may thus have a deﬁcit in Hsp levels due
to a twofold cause: decreased de novo synthesis of Hsp that
characterizes such cells and the long axonal distances along
which the Hsp must be transported to reach the synapse [18].
One solution to this problem might be to synthesize Hsp in
glial cells adjacent to the synapse, release them into the extra-
cellular ﬂuid for uptake by neuronal receptors [17,19]. The
functions of such donated Hsps are not known but probably
include increasing the chaperoning power of the neurone and
protection from programmed cell death which can accompany
neurotransmission [20].ation of European Biochemical Societies.
Fig. 1. Hsp70 is released from cells and may interact with a wide range of target cells. Hsp70 may be released by active secretion mechanisms or from
cells undergoing necrosis. The resulting extracellular Hsp70 (red triangles) may then interact with neuronal cells, monocytes or macrophages or enter
the circulation. Hsp70 may also be released conjugated to antigenic peptides (blue rectangles) and hsp70–peptide complexes are taken up by antigen
presenting cells such as dendritic cells. Such peptides may then be transferred to major histocompatability class I molecules (dark blue rectangles)
through process known as cross-presentation, and such MHC I–peptide complexes can be recognized by CD8+ T lymphocytes leading to T cell
activation. Similar properties have been shown for other Hsp. (For interpretation of the references in colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
Table 1
Intracellular and extracellular properties of HSP and GRP
Chaperone Protein function
Intracellular Extracellular
Hsp27 Chaperone anti-death Anti-inﬂammatory
Hsp60 Chaperonin Pro-inﬂammatory
Hsp70 Chaperone anti-death Immunoregulatory pro-inﬂammatory neuronal agonist
Hsp90 Chaperone evolutionary modulator Pro-immune
Hsp110 Chaperone co-chaperone Pro-immune
grp78 ER chaperone Anti-inﬂammatory
Grp94 ER chaperone Immunoregulatory
Grp170 ER chaperone Pro-immune
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lation following behavioral stress or the trauma associated
with extreme exercise [10,21]. Hsp70 levels increase in the cir-
culation of experimental animals and human subjects after
these physiological stresses although the cellular source and
physiological functions of such Hsp70 are not clear [10,21].
It has been suggested that brown fat tissue is the source of
much of such Hsp70 [22].3. Immune and inﬂammatory eﬀects of extracellular Hsps
Extracellular stress proteins of the Hsp and Grp families
have powerful eﬀects on the immune response [23–25]. These
stress proteins interact with the immune response in a number
of contexts. During exposure to many pathogens, prokaryotic
Hsp are released at high levels and are dominant antigens in
the immunological responses to such pathogens [26,27]. Mam-
malian cells express endogenous stress proteins to high levelsafter trauma or exposure to bacteria or bacterial proteins
[28]. Such stress proteins can be pro-inﬂammatory and lead
to cytokine transcription and release [29,30]. In addition, stress
proteins can act as stimulants of the adaptive immune response
through their ability to bind antigenic peptides during antigen
processing [31]. When such stress protein–peptide complexes
are released from dead and dying cells they bind to receptors
on antigen processing cells and antigens can be delivered to
MHC class I molecules on the surfaces of such cells through
a process known as antigen cross-presentation (Fig. 1)
[32,33]. Such interactions form the basis for molecular chaper-
one based anti-cancer vaccines. Hsp–peptide complexes ex-
tracted from tumors can stimulate a speciﬁc CD8+ T cell
mediated immune response in the tumor bearing host [32,33].
The potency of such vaccines has been ascribed to the ability
of stress proteins to stimulate both the innate and adaptive
arms of the anti-tumor immune response (Fig. 1) [24].
Stress proteins can also be anti-inﬂammatory and such
interactions are noted speciﬁcally in inﬂammatory diseases.
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which recognize common epitopes in mammalian and highly
immunogenic prokaryotic Hsp [34,35]. It was speculated that
the close degree of conservation in the sequences of these stress
proteins might trigger an autoimmune response to mammalian
stress proteins. Interestingly however, application of the corre-
sponding mammalian Hsp suppresses the pro-inﬂammatory
responses to bacterial Hsp epitopes and leads to remission of
inﬂammatory diseases [36]. Heat shock proteins can thus be
both profoundly immunostimulatory or immunosuppressive,
depending on context [34,37].Fig. 2. Release of stress proteins from cells and binding to cell surface
receptors on the donor cells, adjacent cells or distant cells. Hsp or Grp
reach the extracellular microenvironment through active SECRE-
TION or passive release after NECROSIS. The stress proteins can be
recognized by an array of receptors on the TARGET CELL. Cells may
have one or a number of receptors, which may be arrayed in parallel as
here or hierarchically with binding to one receptor inﬂuencing another.4. Mechanisms of Hsp70 release
Hsp70 is not secreted by the classical pathway; its sequence
encodes no secretion leader signal and inhibitors such as
brefeldin A that antagonize transport through the ER-Golgi
system do not inhibit its release. However, a number of non-
canonical pathways for release of ‘‘leaderless’’ proteins exist.
In some cases release of leaderless proteins involves cell lysis
and this may occur both in pathological conditions that give
rise to necrosis or in physiologically regulated release of cyto-
kines [38]. Hsp70 for instance is released when tumor cells un-
dergo necrotic death, presumably when cell membranes
become compromised [11]. It has also been suggested that
Hsp70 may be released and enter the blood stream under a
number of pathological conditions that lead to widespread cell
death [21]. In addition, a second pathway involves release of
intracellular proteins in secretary vesicles [39]. This mechanism
has been observed in macrophages stimulated to release IL-1b
by LPS and extracellular ATP [39]. Stress proteins such as
Hsp27, Hsp70, Hsc70 and Hsp90 can apparently be released
within the lumen of ‘‘exosomes’’ through such a pathway when
B cells for instance are exposed to heat shock [8]. The postula-
tion of vesicles or exosomes as a source of extracellular Hsp70
requires that these structures should rupture or lyse on enter-
ing the extracellular microenvironment [39]. A third secretion
pathway involves the entry of the leaderless protein into secre-
tary lysosomal endosomes, migration of these organelles to the
cell surface and release of the contents of the endolysosome
into the extracellular space [40]. Again this pathway has been
observed in IL-1b secretion by macrophages stimulated with
LPS and ATP [41,42]. Indeed hsp70 has recently been shown
to be secreted from tumor cells and macrophages by this path-
way [6]. Fever range conditions have been shown to induce
Hsp70 to enter endolysosomes and be secreted in an extracel-
lular ATP-dependent manner [6]. Study of these processes is
still in its infancy and further studies are required to determine
the favored pathways for Hsp70 release by neuronal and im-
mune cells.5. Hsp70 uptake mechanisms
Stress proteins including Hsp, Grp and calreticulin interact
with arrange of receptors on target cells (Fig. 2). These include
the oxidized LDL binding protein CD91/LRP found on anti-
gen presenting cells and other cell types [43,44]. It was in fact
proposed that CD91 could be the common receptor for all
immunogenic Hsp, including Hsp 60, 70, Gp96 and calreticulin[43]. However, its role as a direct high/medium aﬃnity Hsp
binder is still not clear. Theriault et al. examined the ability
of Hsp70 in free solution to bind cells with, or without
CD91 expression and observe minimal diﬀerences [15]. In addi-
tion, overexpression of substrate binding domains of CD91 in
cells deﬁcient for Hsp70 binding does not restore Hsp70 bind-
ing [15]. Hsp70 binding may thus involve low aﬃnity interac-
tions or be indirect. In addition, CD40 can function as a
Hsp70 receptor [45]. CD40 is a member of the tumor necrosis
factor receptor family and plays a major in antigen presenting
cell maturation through binding to its counter receptor on acti-
vated T cells (CD40L) [46]. The studies of Lehrner et al.
showed that mycobacterial Hsp70 can bind avidly to CD40,
a ﬁnding which may have major implications suggesting the
ability to activate APC an cause the release of CC cytokines
CCL3, CCL4 and CCL5 [45]. It has also been reported that
human Hsp70 binds to CD40 [47]. However, subsequent stud-
ies indicated that when CD40 is overexpressed in previously
null cells, they fail to acquire hsp70 binding capacity [15].
The exact role of CD40 as a direct binder for mammalian
Hsp70 is thus still in the balance. However, Millar et al.
showed an essential role for CD40 in Hsp70 stimulation of
antigen presenting cells indicating its importance at one of
the stages in the pathways of antigen presentation and T cell
stimulation [48]. As major pattern recognition receptors
(PRR), the Toll Like receptors sparked the interest of number
of groups and instigated investigations of TLR as Hsp recep-
tors. The TLR couple exposure to prokaryotic cell derived
danger signals such as bacterial LPS, lipopeptides and CpG
DNA, to intracellular signal transduction and transcription
pathways that include the NF-jB and interferon response fac-
tor pathways [49]. There are now at least 11 members of the
TLR, most of which have not been tested as Hsp receptors
[49]. However, at least two TLR members function as Hsp
receptors and can couple the binding of Hsp60, Hsp70 and
gp96 to NF-jB activity [30,50–54]. In addition, the cell surface
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also required for Hsp70 induction of the cytokines TNFa, IL-
1b and IL6 [50]. Again, however, some studies suggest that
these interactions between hsp70 and TLR are likely not ex-
erted through the direct binding of Hsp70 to CD14, TLR2
or TLR4, as null cells that stably express Cd14, TLR2 or
TLR4 do not bind avidly to hsp70 [15]. Thus, low aﬃnity
interactions may be involved in TLR activation by Hsp or
an indirect mechanism, involving Hsp binding to a primary
receptor that secondarily activates TLR signaling may be in-
voked. However, previous studies have shown that TLR acti-
vation by hsp70 requires the internalization of the Hsp70;
simple experiments using TLR gene overexpression in Hsp null
cell lines may thus be inadequate to assess direct Hsp–TLR
binding [55]. Another receptor that can directly bind to myco-
bacterial Hsp70 is the chemokine receptor CCRS; this ﬁnding
may have considerable signiﬁcance for signaling cascades in-
duced by Hsp [56].
Scavenger receptors (SR) constitute another family of PRR.
The SR is receptors for modiﬁed forms of lipoproteins includ-
ing oxidized and acetylated low-density lipoproteins (oxLDL
and acLDL). The SR family are subdivided into eight diﬀerent
sub-classes (A–H) and most receptors belonging to this family
are expressed on the surface of APC [57,58]. It has been shown
that Hsp70 can interact with at least three members of the SR
family including LOX-1, SREC-1 and FEEL-1/CLEVER-1
[15,59,60]. Hsp70 can both be bound at high aﬃnity by these
SR and internalized [12,59]. Both Hsp90 and Hsp60 can also
bind to LOX-1 [59]. In addition, Gp96/Grp94 and calreticulin
show signiﬁcant aﬃnity to Scavenger Receptor-A (SR-A) and
SREC-1 and are internalized by this receptor [61]. Extracellu-
lar calreticulin uptake can also be mediated by SREC-1 but
apparently not by LOX-1 [61,62]. Clearly members of the
SR, which are expressed widely in a range of cell types may
play and important role in stress protein binding and internal-
ization [59,60]. Besides its functional relationship to other SR
family members, LOX-1 shares structural homology to type V
c-type lectin family members such as Dectin-1, NKG2D and
CD94 [63]. Previous studies have demonstrated that another
type V c-type lectin CD94 binds to Hsp70 but not to type II
c-type lectin DC-SIGN [15,64]. Although of the c-type lectins,
Dectin-1 shares the greatest structural homology with LOX-1,
Hsp70 binding was not detected in CHO over-expressing Dec-
tin-1. However, a signiﬁcant aﬃnity was seen between Hsp70
and C type lectins found in NK cells such as NKG2D and
to a lesser extent the heterodimer CD94/NKG2A. Binding to
these c-type lectins was selective in that other family members
overexpressed in CHO cells, including DC-SIGN, CLEC-1
and CLEC-2 showed minimal Hsp70 association (J. Theriault
and S.K. Calderwood, unpublished). Thus, a number of c-type
lectins can serve as receptors for Hsp70 although the conserved
c-type lectin domain was not the sole determinant required for
Hsp70 interaction, as indicated by Hsp70 binding to unrelated
SR such as SREC-1 that do not contain such a domain. C-type
lectins may play a signiﬁcant role in interaction of Hsp70
expressing tumor cells with NK cells [65].
This perplexingly large group of receptors may reﬂect the
large and heterogeneous group of stress proteins often with
radically diﬀerent cellular eﬀects (Table 1). Indeed, we have
found that even between quite closely related members of the
Hsp70 family there are diﬀerences in interactions with individ-
ual SR members (J. Theriault and S.K. Calderwood, unpub-lished). In addition, stress proteins likely recognize diﬀerent
receptors on diﬀerent cell types [15]. The multiplicity of recep-
tors may also indicate specialization for individual functions:
receptors such as the TLR, CD40 and CCR5 may be adapted
for transmembrane signaling while CD91 and SR may play
more important roles in internalization of Hsp (Fig. 2).6. Conclusions
Secretion of heat shock proteins and glucose regulated pro-
teins thus extends the reach of the stress response into the
extracellular microenvironment. Such proteins escape the plas-
ma membrane through both active secretion and passive loss
from necrotic cells. Once in the extracellular milieu, the stress
proteins can increase stress resistance after binding to stress-
sensitive recipient cells such as neurones, can signal tissue
destruction and danger to inﬂammatory cells and aid in immu-
nosurveillance by transporting intracellular peptides to distant
immune cells.
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